Intravesical administration of EGF- dextran conjugates in patients with superficial bladder cancer. | Eur Urol;38(5): 584-9, 2000 Nov. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

Intravesical administration of EGF- dextran conjugates in patients with superficial bladder cancer.

Bue, P; Holmberg, A R; Márquez, M; Westlin, J E; Nilsson, S; Malmström, P U.

Affiliation

Bue P; Department of Urology, Uppsala University, Uppsala, Sweden.

Eur Urol ; 38(5): 584-9, 2000 Nov.

Article in En | MEDLINE | ID: mdl-11096240

Subject(s)

Dextrans/administration & dosage; Epidermal Growth Factor/administration & dosage; Urinary Bladder Neoplasms/drug therapy; Administration, Intravesical; Aged; Aged, 80 and over; Drug Carriers; Female; Humans; Male

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Urinary Bladder Neoplasms / Dextrans / Epidermal Growth Factor Limits: Aged / Aged80 / Female / Humans / Male Language: En Journal: Eur Urol Year: 2000 Document type: Article Affiliation country: Sweden Country of publication: Switzerland

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Urinary Bladder Neoplasms / Dextrans / Epidermal Growth Factor Limits: Aged / Aged80 / Female / Humans / Male Language: En Journal: Eur Urol Year: 2000 Document type: Article Affiliation country: Sweden Country of publication: Switzerland